Free Weekly Vaccines Industry Newsletter Get the latest news about Research Breakthroughs, R&D Trends, Clinical Trials, and Vaccine Production sent straight to your Inbox. Join over 25,000 lab research professionals who subscribe to FierceVaccines for FREE!
The vaccine market has long been dominated by the Big 3--Sanofi, Merck and GlaxoSmithKline--with Pfizer and Novartis trailing the trio on the list of revenue-generators. But things are changing at the top.
Adherence-Informed Clinical Trials to Achieve and Maintain Maximal Treatment Efficacy
| Tuesday, June 23 | 11:00am ET / 8:00am PT | Presented By: MWV Healthcare
This webinar will address the impact of medication non-adherence in clinical trials. Accurate adherence measurement is necessary to evaluate a compound's true potential and increase the likelihood of a successful trial outcome. Register today!
CYRAMZA® (ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology
Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.
Teva to Present New Findings at the American Headache Society (AHS) Meeting – Analysis of Migraine Phase IIb Studies Provides Novel Insights into TEV-48125 Efficacy and Safety in Both Episodic & Chronic Migraine
Lilly's investigational medicine for prevention of migraine met primary endpoint in a Phase 2b study
FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!